NCR3 and neoplasm: The presence of B7–H6 on the surface of tumor cells makes them susceptible to NKp30-mediated killing by NK cells, while the binding of B7–H6 with NKp30c, the inhibitory isoform of NKp30, induce NK cells to produce IL-10.